The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.42BCNY
359.70M · vs all stocks (USD)
Updated Aug 20, 2026
Revenue (TTM)
827.53MCNY
122.90M · vs all stocks (USD)
Updated Aug 20, 2026
Profit Margin
-14.02%
Updated Aug 20, 2026
Beta
0.3250x
vs all stocks
Updated Aug 20, 2026
52-Week Change
9.75%
vs all stocks
Updated Aug 20, 2026
Market Capitalization
2.42BCNY
359.70M · vs all stocks (USD)
Updated Aug 20, 2026
Enterprise Value
2.35BCNY
348.51M · vs all stocks (USD)
Updated Aug 20, 2026
Forward P/E
9.57x
Updated Aug 20, 2026
Price to Sales (TTM)
2.90x
Updated Aug 20, 2026
Price to Book (MRQ)
3.99x
Updated Aug 20, 2026
Enterprise to Revenue
2.84x
Updated Aug 20, 2026
Enterprise to EBITDA
60.64x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 16.05×.Updated Aug 20, 2026
Gross Margin
5.45%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 10.7%.Updated Aug 20, 2026
Profit Margin
-14.02%
Updated Aug 20, 2026
Operating Margin
-23.26%
Updated Aug 20, 2026
Return on Assets (TTM)
-1.49%
Updated Aug 20, 2026
Return on Equity (TTM)
-18.37%
Updated Aug 20, 2026
Revenue (TTM)
827.53MCNY
122.90M · vs all stocks (USD)
Updated Aug 20, 2026
Revenue per Share (TTM)
4.09CNYUpdated Aug 20, 2026
Quarterly Revenue Growth
-38.70%
Updated Aug 20, 2026
Gross Profit (TTM)
88.57MCNY
13.15M · vs all stocks (USD)
Updated Aug 20, 2026
EBITDA (TTM)
146.23MCNY
21.72M · vs all stocks (USD)
Updated Aug 20, 2026
Net Income (TTM)
-116.03MCNY
-17.23M · vs all stocks (USD)
Updated Aug 20, 2026
Operating Cash Flow (TTM)
195.91MCNY
29.10M · vs all stocks (USD)
Updated Aug 20, 2026
Levered Free Cash Flow (TTM)
145.29MCNY
21.58M · vs all stocks (USD)
Updated Aug 20, 2026
5-Year Average Dividend Yield
0.65%
vs all stocks
Updated Aug 20, 2026
Payout Ratio
125.00%
Updated Aug 20, 2026
Minority Interest (Equity)
3.99MCNYFY2025 · Dec 31, 2025
Revenue
978.08MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
790.11MCNYFY2025 · Dec 31, 2025
Gross Profit
187.97MCNYFY2025 · Dec 31, 2025
Operating Income
71.11MCNY
10.56M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
41.99MCNYFY2025 · Dec 31, 2025
Income Tax Expense
21.60MCNYFY2025 · Dec 31, 2025
Net Income
20.39MCNYFY2025 · Dec 31, 2025
EBIT
57.95MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
146.23MCNYFY2025 · Dec 31, 2025
Research & Development
29.03MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
35.51MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
4.60MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
3.56MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
15.97MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.1100CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.1100CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
200.96MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
200.96MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
20.39MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
1.72MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
312.96MCNYFY2025 · Dec 31, 2025
Free Cash Flow
259.23MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
216.34MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
20.39MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
28.25MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
248.63MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
15.69MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-53.73MCNYFY2025 · Dec 31, 2025
Net Acquisitions
-2.10MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-316.13MCNYFY2025 · Dec 31, 2025
Sale of Investments
205.79MCNYFY2025 · Dec 31, 2025
Other Investing Activity
6.40MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-159.77MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
449.50MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-483.50MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-24.59MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-61.87MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-120.46MCNYFY2025 · Dec 31, 2025
Shares Outstanding
200.99MSharesUpdated Aug 20, 2026
Float Shares
156.70MSharesUpdated Aug 20, 2026
% Held by Insiders
22.14%
vs all stocks
Updated Aug 20, 2026
% Held by Institutions
2.37%
vs all stocks
Updated Aug 20, 2026
Total Cash (MRQ)
253.52MCNY
37.65M · vs all stocks (USD)
Updated Aug 20, 2026
Total Cash per Share (MRQ)
1.26CNYUpdated Aug 20, 2026
Total Debt (MRQ)
244.06MCNY
36.25M · vs all stocks (USD)
Updated Aug 20, 2026
Total Debt to Equity (MRQ)
0.4029x
Updated Aug 20, 2026
Current Ratio (MRQ)
1.20x
Updated Aug 20, 2026
Book Value per Share (MRQ)
3.00CNYUpdated Aug 20, 2026
Total Assets
1.53BCNY
227.65M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.01BCNYFY2025 · Dec 31, 2025
Total Liabilities
843.31MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
521.60MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
4.22MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
839.10MCNYFY2025 · Dec 31, 2025
Cash
215.83MCNYFY2025 · Dec 31, 2025
Cash Equivalents
7.04MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
222.87MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
115.63MCNYFY2025 · Dec 31, 2025
Accounts Receivable
220.50MCNYFY2025 · Dec 31, 2025
Inventory
33.10MCNYFY2025 · Dec 31, 2025
Accounts Payable
315.54MCNYFY2025 · Dec 31, 2025
Short-term Debt
348.31MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
134.11MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
200.99MCNYFY2025 · Dec 31, 2025
Retained Earnings
138.85MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
689.45MCNY
102.40M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
8.44CNYUpdated Aug 20, 2026
52-Week High
17.90CNYUpdated Aug 20, 2026
52-Week Change
9.75%
vs all stocks
Updated Aug 20, 2026
Beta
0.3250x
vs all stocks
Updated Aug 20, 2026
50-Day MA
11.40CNYUpdated Aug 20, 2026
200-Day MA
11.85CNYUpdated Aug 20, 2026
Avg 10-Day Volume
24.97MSharesUpdated Aug 20, 2026
Avg 30-Day Volume
23.40MSharesUpdated Aug 20, 2026
Diluted EPS (TTM)
-0.5800CNYUpdated Aug 20, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.75: safe zoneNotable
Altman Z-Score: 2.75
Supply Chain
Upstream position: supplies 5 industries, depends on 3Notable
Outgoing: 5.00Incoming: 3.00
Scale
Levered free cash flow is $21.58M, above the global median of $16.24MNotable